APO Research

APO RESEARCH · REPORT

Megestrol

Selected research

Industry Growth & Trends

Global Megestrol Industry Growth and Trends Forecast to 2032

Market perspective

The global Megestrol market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Megestrol is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Megestrol is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Megestrol is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Megestrol include Abbott, Takeda, Sandoz, Novartis, Mylan, Pfizer, GSK, Mayne Pharma and Guccess, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Megestrol market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Megestrol market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Megestrol market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Megestrol.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Megestrol market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Megestrol Market by Company

Abbott

Takeda

Sandoz

Novartis

Mylan

Pfizer

GSK

Mayne Pharma

Guccess

Bristol Myers Squibb

Abnova

Megestrol Segment by Type

Oral Suspension

Tablet

Injection

Others

Megestrol Segment by Application

Hospital

Clinic

Others

Megestrol Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Megestrol market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Megestrol and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Megestrol.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Megestrol manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Megestrol in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Oral Suspension Table 2. Major Company of Tablet Table 3. Major Company of Injection Table 4. Major Company of Others Table 5. Global Megestrol Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Megestrol Sales by Type (2021-2026) & (k units) Table 7. Global Megestrol Sales Market Share in Volume by Type (2021-2026) Table 8. Global Megestrol Sales by Type (2021-2026) & (US$ Million) Table 9. Global Megestrol Sales Market Share in Value by Type (2021-2026) Table 10. Global Megestrol Price by Type (2021-2026) & (US$/unit) Table 11. Global Megestrol Sales by Type (2027-2032) & (k units) Table 12. Global Megestrol Sales Market Share in Volume by Type (2027-2032) Table 13. Global Megestrol Sales by Type (2027-2032) & (US$ Million) Table 14. Global Megestrol Sales Market Share in Value by Type (2027-2032) Table 15. Global Megestrol Price by Type (2027-2032) & (US$/unit) Table 16. North America Megestrol Sales by Type (2021-2026) & (k units) Table 17. North America Megestrol Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Megestrol Sales by Type (2021-2026) & (k units) Table 19. Europe Megestrol Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Megestrol Sales by Type (2021-2026) & (k units) Table 21. Asia-Pacific Megestrol Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Megestrol Sales by Type (2021-2026) & (k units) Table 23. Latin America Megestrol Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Megestrol Sales by Type (2021-2026) & (k units) Table 25. Middle East and Africa Megestrol Sales by Type (2021-2026) & (US$ Million) Table 26. Megestrol Industry Trends Table 27. Megestrol Industry Drivers Table 28. Megestrol Industry Opportunities and Challenges Table 29. Megestrol Industry Restraints Table 30. Global Megestrol Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Megestrol Revenue Market Share by Company (2021-2026) Table 32. Global Megestrol Sales by Company (2021-2026) & (k units) Table 33. Global Megestrol Sales Share by Company (2021-2026) Table 34. Global Megestrol Market Price by Company (2021-2026) & (US$/unit) Table 35. Global Megestrol Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Megestrol Major Company Production Sites and Headquarters Table 37. Global Megestrol Company, Product Type & Application Table 38. Global Megestrol Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Megestrol by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Megestrol Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Megestrol Sales by Region (2021-2026) & (k units) Table 43. Global Megestrol Sales Market Share in Volume by Region (2021-2026) Table 44. Global Megestrol Sales by Region (2021-2026) & (US$ Million) Table 45. Global Megestrol Sales Market Share in Value by Region (2021-2026) Table 46. Global Megestrol Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 47. Global Megestrol Sales by Region (2027-2032) & (k units) Table 48. Global Megestrol Sales Market Share in Volume by Region (2027-2032) Table 49. Global Megestrol Sales by Region (2027-2032) & (US$ Million) Table 50. Global Megestrol Sales Market Share in Value by Region (2027-2032) Table 51. Global Megestrol Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 52. Global Megestrol Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Megestrol Sales by Application (2021-2026) & (k units) Table 54. Global Megestrol Sales Market Share in Volume by Application (2021-2026) Table 55. Global Megestrol Sales by Application (2021-2026) & (US$ Million) Table 56. Global Megestrol Sales Market Share in Value by Application (2021-2026) Table 57. Global Megestrol Price by Application (2021-2026) & (US$/unit) Table 58. Global Megestrol Sales by Application (2027-2032) & (k units) Table 59. Global Megestrol Sales Market Share in Volume by Application (2027-2032) Table 60. Global Megestrol Sales by Application (2027-2032) & (US$ Million) Table 61. Global Megestrol Sales Market Share in Value by Application (2027-2032) Table 62. Global Megestrol Price by Application (2027-2032) & (US$/unit) Table 63. North America Megestrol Sales by Application (2021-2026) & (k units) Table 64. North America Megestrol Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Megestrol Sales by Application (2021-2026) & (k units) Table 66. Europe Megestrol Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Megestrol Sales by Application (2021-2026) & (k units) Table 68. Asia-Pacific Megestrol Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Megestrol Sales by Application (2021-2026) & (k units) Table 70. Latin America Megestrol Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Megestrol Sales by Application (2021-2026) & (k units) Table 72. Middle East and Africa Megestrol Sales by Application (2021-2026) & (US$ Million) Table 73. Abbott Company Information Table 74. Abbott Business Overview Table 75. Abbott Megestrol Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Abbott Megestrol Product Portfolio Table 77. Abbott Recent Development Table 78. Takeda Company Information Table 79. Takeda Business Overview Table 80. Takeda Megestrol Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. Takeda Megestrol Product Portfolio Table 82. Takeda Recent Development Table 83. Sandoz Company Information Table 84. Sandoz Business Overview Table 85. Sandoz Megestrol Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. Sandoz Megestrol Product Portfolio Table 87. Sandoz Recent Development Table 88. Novartis Company Information Table 89. Novartis Business Overview Table 90. Novartis Megestrol Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. Novartis Megestrol Product Portfolio Table 92. Novartis Recent Development Table 93. Mylan Company Information Table 94. Mylan Business Overview Table 95. Mylan Megestrol Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 96. Mylan Megestrol Product Portfolio Table 97. Mylan Recent Development Table 98. Pfizer Company Information Table 99. Pfizer Business Overview Table 100. Pfizer Megestrol Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 101. Pfizer Megestrol Product Portfolio Table 102. Pfizer Recent Development Table 103. GSK Company Information Table 104. GSK Business Overview Table 105. GSK Megestrol Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 106. GSK Megestrol Product Portfolio Table 107. GSK Recent Development Table 108. Mayne Pharma Company Information Table 109. Mayne Pharma Business Overview Table 110. Mayne Pharma Megestrol Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 111. Mayne Pharma Megestrol Product Portfolio Table 112. Mayne Pharma Recent Development Table 113. Guccess Company Information Table 114. Guccess Business Overview Table 115. Guccess Megestrol Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 116. Guccess Megestrol Product Portfolio Table 117. Guccess Recent Development Table 118. Bristol Myers Squibb Company Information Table 119. Bristol Myers Squibb Business Overview Table 120. Bristol Myers Squibb Megestrol Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 121. Bristol Myers Squibb Megestrol Product Portfolio Table 122. Bristol Myers Squibb Recent Development Table 123. Abnova Company Information Table 124. Abnova Business Overview Table 125. Abnova Megestrol Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 126. Abnova Megestrol Product Portfolio Table 127. Abnova Recent Development Table 128. North America Megestrol Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 129. North America Megestrol Sales by Country (2021-2026) & (k units) Table 130. North America Megestrol Sales Market Share by Country (2021-2026) Table 131. North America Megestrol Sales Forecast by Country (2027-2032) & (k units) Table 132. North America Megestrol Sales Market Share Forecast by Country (2027-2032) Table 133. North America Megestrol Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. North America Megestrol Market Size by Country (2021-2026) & (US$ Million) Table 135. North America Megestrol Market Share by Country (2021-2026) Table 136. North America Megestrol Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. North America Megestrol Market Share Forecast by Country (2027-2032) Table 138. Europe Megestrol Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 139. Europe Megestrol Sales by Country (2021-2026) & (k units) Table 140. Europe Megestrol Sales Market Share by Country (2021-2026) Table 141. Europe Megestrol Sales Forecast by Country (2027-2032) & (k units) Table 142. Europe Megestrol Sales Market Share Forecast by Country (2027-2032) Table 143. Europe Megestrol Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Europe Megestrol Market Size by Country (2021-2026) & (US$ Million) Table 145. Europe Megestrol Market Share by Country (2021-2026) Table 146. Europe Megestrol Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Europe Megestrol Market Share Forecast by Country (2027-2032) Table 148. Asia-Pacific Megestrol Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 149. Asia-Pacific Megestrol Sales by Country (2021-2026) & (k units) Table 150. Asia-Pacific Megestrol Sales Market Share by Country (2021-2026) Table 151. Asia-Pacific Megestrol Sales Forecast by Country (2027-2032) & (k units) Table 152. Asia-Pacific Megestrol Sales Market Share Forecast by Country (2027-2032) Table 153. Asia-Pacific Megestrol Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Asia-Pacific Megestrol Market Size by Country (2021-2026) & (US$ Million) Table 155. Asia-Pacific Megestrol Market Share by Country (2021-2026) Table 156. Asia-Pacific Megestrol Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Asia-Pacific Megestrol Market Share Forecast by Country (2027-2032) Table 158. Latin America Megestrol Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 159. Latin America Megestrol Sales by Country (2021-2026) & (k units) Table 160. Latin America Megestrol Sales Market Share by Country (2021-2026) Table 161. Latin America Megestrol Sales Forecast by Country (2027-2032) & (k units) Table 162. Latin America Megestrol Sales Market Share Forecast by Country (2027-2032) Table 163. Latin America Megestrol Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 164. Latin America Megestrol Market Size by Country (2021-2026) & (US$ Million) Table 165. Latin America Megestrol Market Share by Country (2021-2026) Table 166. Latin America Megestrol Market Size Forecast by Country (2027-2032) & (US$ Million) Table 167. Latin America Megestrol Market Share Forecast by Country (2027-2032) Table 168. Middle East and Africa Megestrol Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 169. Middle East and Africa Megestrol Sales by Country (2021-2026) & (k units) Table 170. Middle East and Africa Megestrol Sales Market Share by Country (2021-2026) Table 171. Middle East and Africa Megestrol Sales Forecast by Country (2027-2032) & (k units) Table 172. Middle East and Africa Megestrol Sales Market Share Forecast by Country (2027-2032) Table 173. Middle East and Africa Megestrol Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 174. Middle East and Africa Megestrol Market Size by Country (2021-2026) & (US$ Million) Table 175. Middle East and Africa Megestrol Market Share by Country (2021-2026) Table 176. Middle East and Africa Megestrol Market Size Forecast by Country (2027-2032) & (US$ Million) Table 177. Middle East and Africa Megestrol Market Share Forecast by Country (2027-2032) Table 178. Key Raw Materials Table 179. Raw Materials Key Suppliers Table 180. Megestrol Distributors List Table 181. Megestrol Customers List Table 182. Research Programs/Design for This Report Table 183. Authors List of This Report Table 184. Secondary Sources Table 185. Primary Sources List of Figures Figure 1. Megestrol Image Figure 2. Global Megestrol Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Megestrol Market Size (2021-2032) & (US$ Million) Figure 4. Global Megestrol Sales (2021-2032) & (k units) Figure 5. Oral Suspension Image Figure 6. Global Oral Suspension Sales YoY Growth (2021-2032) & (k units) Figure 7. Tablet Image Figure 8. Global Tablet Sales YoY Growth (2021-2032) & (k units) Figure 9. Injection Image Figure 10. Global Injection Sales YoY Growth (2021-2032) & (k units) Figure 11. Others Image Figure 12. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 13. Global Megestrol Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Megestrol Market Share by Type 2025 VS 2032 Figure 15. North America Megestrol Sales Market Share in Volume by Type in 2025 Figure 16. North America Megestrol Sales Market Share in Value by Type in 2025 Figure 17. Europe Megestrol Sales Market Share in Volume by Type in 2025 Figure 18. Europe Megestrol Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Megestrol Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Megestrol Sales Market Share in Value by Type in 2025 Figure 21. Latin America Megestrol Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Megestrol Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Megestrol Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Megestrol Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Megestrol Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Hospital Image Figure 28. Global Hospital Sales YoY Growth (2021-2032) & (k units) Figure 29. Clinic Image Figure 30. Global Clinic Sales YoY Growth (2021-2032) & (k units) Figure 31. Others Image Figure 32. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 33. Global Megestrol Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Megestrol Market Share by Application 2025 VS 2032 Figure 35. North America Megestrol Sales Market Share in Volume by Application in 2025 Figure 36. North America Megestrol Sales Market Share in Value by Application in 2025 Figure 37. Europe Megestrol Sales Market Share in Volume by Application in 2025 Figure 38. Europe Megestrol Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Megestrol Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Megestrol Sales Market Share in Value by Application in 2025 Figure 41. Latin America Megestrol Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Megestrol Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Megestrol Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Megestrol Sales Market Share in Value by Application in 2025 Figure 45. North America Megestrol Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 46. North America Megestrol Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Megestrol Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Megestrol Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Megestrol Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. Europe Megestrol Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Megestrol Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Megestrol Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Megestrol Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Asia-Pacific Megestrol Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Megestrol Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Megestrol Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Megestrol Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Latin America Megestrol Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Megestrol Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Megestrol Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Megestrol Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 62. Middle East and Africa Megestrol Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Megestrol Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Megestrol Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Megestrol Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Megestrol Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Oral Suspension
  • Tablet
  • Injection
  • Others
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Abbott
  • Takeda
  • Sandoz
  • Novartis
  • Mylan
  • Pfizer
  • GSK
  • Mayne Pharma
  • Guccess
  • Bristol Myers Squibb
  • Abnova

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Megestrol Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Megestrol Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Megestrol Market by Type
  6. 1.3.1 Oral Suspension
  7. 1.3.2 Tablet
  8. 1.3.3 Injection
  9. 1.3.4 Others
  10. 1.4 Global Megestrol Market Size by Type
  11. 1.4.1 Global Megestrol Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Megestrol Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Megestrol Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Megestrol Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Megestrol Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Megestrol Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Megestrol Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Megestrol Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Megestrol Industry Trends
  2. 2.2 Megestrol Industry Drivers
  3. 2.3 Megestrol Industry Opportunities and Challenges
  4. 2.4 Megestrol Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Megestrol Revenue (2021-2026)
  2. 3.2 Global Top Players by Megestrol Sales (2021-2026)
  3. 3.3 Global Top Players by Megestrol Price (2021-2026)
  4. 3.4 Global Megestrol Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Megestrol Major Company Production Sites & Headquarters
  6. 3.6 Global Megestrol Company, Product Type & Application
  7. 3.7 Global Megestrol Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Megestrol Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Megestrol Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Megestrol Tier 1, Tier 2, and Tier 3
4 Megestrol Regional Status and Outlook
  1. 4.1 Global Megestrol Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Megestrol Historic Market Size by Region
  3. 4.2.1 Global Megestrol Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Megestrol Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Megestrol Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Megestrol Forecasted Market Size by Region
  7. 4.3.1 Global Megestrol Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Megestrol Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Megestrol Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Megestrol by Application
  1. 5.1 Megestrol Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Megestrol Market Size by Application
  6. 5.2.1 Global Megestrol Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Megestrol Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Megestrol Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Megestrol Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Megestrol Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Megestrol Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Megestrol Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Megestrol Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Abbott
  2. 6.1.1 Abbott Company Information
  3. 6.1.2 Abbott Business Overview
  4. 6.1.3 Abbott Megestrol Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Abbott Megestrol Product Portfolio
  6. 6.1.5 Abbott Recent Developments
  7. 6.2 Takeda
  8. 6.2.1 Takeda Company Information
  9. 6.2.2 Takeda Business Overview
  10. 6.2.3 Takeda Megestrol Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Takeda Megestrol Product Portfolio
  12. 6.2.5 Takeda Recent Developments
  13. 6.3 Sandoz
  14. 6.3.1 Sandoz Company Information
  15. 6.3.2 Sandoz Business Overview
  16. 6.3.3 Sandoz Megestrol Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Sandoz Megestrol Product Portfolio
  18. 6.3.5 Sandoz Recent Developments
  19. 6.4 Novartis
  20. 6.4.1 Novartis Company Information
  21. 6.4.2 Novartis Business Overview
  22. 6.4.3 Novartis Megestrol Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Novartis Megestrol Product Portfolio
  24. 6.4.5 Novartis Recent Developments
  25. 6.5 Mylan
  26. 6.5.1 Mylan Company Information
  27. 6.5.2 Mylan Business Overview
  28. 6.5.3 Mylan Megestrol Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Mylan Megestrol Product Portfolio
  30. 6.5.5 Mylan Recent Developments
  31. 6.6 Pfizer
  32. 6.6.1 Pfizer Company Information
  33. 6.6.2 Pfizer Business Overview
  34. 6.6.3 Pfizer Megestrol Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Pfizer Megestrol Product Portfolio
  36. 6.6.5 Pfizer Recent Developments
  37. 6.7 GSK
  38. 6.7.1 GSK Company Information
  39. 6.7.2 GSK Business Overview
  40. 6.7.3 GSK Megestrol Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 GSK Megestrol Product Portfolio
  42. 6.7.5 GSK Recent Developments
  43. 6.8 Mayne Pharma
  44. 6.8.1 Mayne Pharma Company Information
  45. 6.8.2 Mayne Pharma Business Overview
  46. 6.8.3 Mayne Pharma Megestrol Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Mayne Pharma Megestrol Product Portfolio
  48. 6.8.5 Mayne Pharma Recent Developments
  49. 6.9 Guccess
  50. 6.9.1 Guccess Company Information
  51. 6.9.2 Guccess Business Overview
  52. 6.9.3 Guccess Megestrol Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Guccess Megestrol Product Portfolio
  54. 6.9.5 Guccess Recent Developments
  55. 6.10 Bristol Myers Squibb
  56. 6.10.1 Bristol Myers Squibb Company Information
  57. 6.10.2 Bristol Myers Squibb Business Overview
  58. 6.10.3 Bristol Myers Squibb Megestrol Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Bristol Myers Squibb Megestrol Product Portfolio
  60. 6.10.5 Bristol Myers Squibb Recent Developments
  61. 6.11 Abnova
  62. 6.11.1 Abnova Company Information
  63. 6.11.2 Abnova Business Overview
  64. 6.11.3 Abnova Megestrol Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Abnova Megestrol Product Portfolio
  66. 6.11.5 Abnova Recent Developments
7 North America by Country
  1. 7.1 North America Megestrol Sales by Country
  2. 7.1.1 North America Megestrol Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Megestrol Sales by Country (2021-2026)
  4. 7.1.3 North America Megestrol Sales Forecast by Country (2027-2032)
  5. 7.2 North America Megestrol Market Size by Country
  6. 7.2.1 North America Megestrol Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Megestrol Market Size by Country (2021-2026)
  8. 7.2.3 North America Megestrol Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Megestrol Sales by Country
  2. 8.1.1 Europe Megestrol Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Megestrol Sales by Country (2021-2026)
  4. 8.1.3 Europe Megestrol Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Megestrol Market Size by Country
  6. 8.2.1 Europe Megestrol Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Megestrol Market Size by Country (2021-2026)
  8. 8.2.3 Europe Megestrol Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Megestrol Sales by Country
  2. 9.1.1 Asia-Pacific Megestrol Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Megestrol Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Megestrol Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Megestrol Market Size by Country
  6. 9.2.1 Asia-Pacific Megestrol Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Megestrol Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Megestrol Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Megestrol Sales by Country
  2. 10.1.1 South America Megestrol Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Megestrol Sales by Country (2021-2026)
  4. 10.1.3 South America Megestrol Sales Forecast by Country (2027-2032)
  5. 10.2 South America Megestrol Market Size by Country
  6. 10.2.1 South America Megestrol Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Megestrol Market Size by Country (2021-2026)
  8. 10.2.3 South America Megestrol Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Megestrol Sales by Country
  2. 11.1.1 Middle East and Africa Megestrol Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Megestrol Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Megestrol Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Megestrol Market Size by Country
  6. 11.2.1 Middle East and Africa Megestrol Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Megestrol Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Megestrol Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Megestrol Value Chain Analysis
  2. 12.1.1 Megestrol Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Megestrol Production Mode & Process
  7. 12.2 Megestrol Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Megestrol Distributors
  10. 12.2.3 Megestrol Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research